DENVER - Jane Staveley, a Principal Environmental Scientist for ARCADIS (EURONEXT: ARCAD), the international consultancy, design, engineering and management services company, will moderate a distinguished panel of experts on the topic of 'Pharmaceuticals in Our Water: Concerns and Responses' during a briefing in the Rayburn House Office Building today, September 14. The briefing will be held from noon to 1:30 p.m. and is presented by the American Chemical Society's Science & the Congress Project, the Society for Risk Analysis and the Society of Toxicology, with honorary co-host, the House Science and Technology Committee.
With a focus on the presence of pharmaceuticals in waterways and drinking water throughout the United States, the briefing is designed to explore what is known about the relative contributions from different types of drugs, their persistence in the environment, and the best methods of drug disposal to reduce the amount getting into the environment.
'I look forward to guiding the panelists in this important discussion as we explore what is known and still unknown about the potential impacts of water-borne pharmaceuticals on human health and ecological receptors,' said Staveley. 'We also will discuss what steps can be taken to maintain the health benefits of drugs, while at the same time mitigating any unintended consequences from their presence in our water.'
Renowned scientists comprising the panel include Mae Wu from the Natural Resources Defense Council; Shane Snyder from the University of Arizona; Sierra Fletcher from the Product Stewardship Institute; and Richard Williams, formerly of Pfizer, Inc.
Staveley brings a wealth of knowledge to her role as moderator, given her more than 30 years of experience in both the public and private sectors working on myriad environmental issues. In addition to her role with ARCADIS, she is currently the President of the Society of Environmental Toxicology and Chemistry (SETAC) and is active in SETAC's advisory group on Pharmaceuticals in the Environment.